AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
RENO, NEV. -- Increased maternal morbidity is significantly associated with magnesium sulfate tocolysis that lasts longer than 48 hours, a retrospective study has demonstrated.
Investigators compared 78 women who received MgS[O.sub.4] tocolysis for longer than 48 hours with 77 women who received MgS[O.sub.4] tocolysis for 48 hours or less. Women who received prolonged tocolysis were significantly more likely to have at least one adverse event (56.4% vs. 28.5%).
The most common adverse events were chest tightness, pulmonary edema, and visual disturbances, investigators wrote in a poster presentation at the annual meeting of the Society for Maternal-Fetal Medicine.
Babies born to the two groups of mothers had similar Apgar scores, hypotonia, and neonatal mortality rates. But ...
Source: HighBeam Research, Maternal morbidity tied to prolonged MgS[O.sub.4]...